Invention Grant
- Patent Title: Antisense modulation of GCCR expression
- Patent Title (中): GCCR表达的反义调制
-
Application No.: US14523751Application Date: 2014-10-24
-
Publication No.: US09567587B2Publication Date: 2017-02-14
- Inventor: Susan M. Freier , Sanjay Bhanot
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Ionis Pharmaceuticals, Inc. Patent Dept.
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; A61K31/70 ; C12N15/113 ; A61K31/7088 ; A61K45/06 ; A61K31/7115 ; A61K31/712 ; A61K31/7125 ; C12N5/00
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of GCCR mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate metabolic disease, for example, diabetes, or a symptom thereof.
Public/Granted literature
- US20150141493A1 ANTISENSE MODULATION OF GCCR EXPRESSION Public/Granted day:2015-05-21
Information query
